Cardiomyopathy, Hypertrophic
"Cardiomyopathy, Hypertrophic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
| Descriptor ID |
D002312
|
| MeSH Number(s) |
C14.280.238.100 C14.280.484.150.070.160
|
| Concept/Terms |
Cardiomyopathy, Hypertrophic- Cardiomyopathy, Hypertrophic
- Cardiomyopathies, Hypertrophic
- Hypertrophic Cardiomyopathies
- Hypertrophic Cardiomyopathy
- Cardiomyopathy, Hypertrophic Obstructive
- Cardiomyopathies, Hypertrophic Obstructive
- Hypertrophic Obstructive Cardiomyopathies
- Hypertrophic Obstructive Cardiomyopathy
- Obstructive Cardiomyopathies, Hypertrophic
- Obstructive Cardiomyopathy, Hypertrophic
|
Below are MeSH descriptors whose meaning is more general than "Cardiomyopathy, Hypertrophic".
Below are MeSH descriptors whose meaning is more specific than "Cardiomyopathy, Hypertrophic".
This graph shows the total number of publications written about "Cardiomyopathy, Hypertrophic" by people in this website by year, and whether "Cardiomyopathy, Hypertrophic" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 3 | 3 | 6 |
| 1999 | 3 | 2 | 5 |
| 2000 | 4 | 0 | 4 |
| 2001 | 5 | 0 | 5 |
| 2002 | 3 | 2 | 5 |
| 2003 | 3 | 1 | 4 |
| 2004 | 6 | 0 | 6 |
| 2005 | 6 | 0 | 6 |
| 2006 | 2 | 1 | 3 |
| 2007 | 6 | 3 | 9 |
| 2008 | 5 | 5 | 10 |
| 2009 | 8 | 1 | 9 |
| 2010 | 7 | 1 | 8 |
| 2011 | 9 | 1 | 10 |
| 2012 | 10 | 0 | 10 |
| 2013 | 15 | 1 | 16 |
| 2014 | 15 | 1 | 16 |
| 2015 | 18 | 2 | 20 |
| 2016 | 18 | 4 | 22 |
| 2017 | 22 | 2 | 24 |
| 2018 | 20 | 1 | 21 |
| 2019 | 18 | 1 | 19 |
| 2020 | 13 | 0 | 13 |
| 2021 | 16 | 1 | 17 |
| 2022 | 21 | 0 | 21 |
| 2023 | 29 | 1 | 30 |
| 2024 | 26 | 1 | 27 |
| 2025 | 2 | 0 | 2 |
Below are the most recent publications written about "Cardiomyopathy, Hypertrophic" by people in Profiles.
-
Aficamten vs Metoprolol for Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM Rationale, Study Design, and Baseline Characteristics. JACC Heart Fail. 2025 Feb; 13(2):346-357.
-
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Design, Rationale, and Baseline Characteristics of ODYSSEY-HCM. JACC Heart Fail. 2025 Feb; 13(2):358-370.
-
Transcriptomic and genetic profiling in a spontaneous non-human primate model of hypertrophic cardiomyopathy and sudden cardiac death. Sci Rep. 2024 Dec 28; 14(1):31344.
-
Single Cell Transcriptomic Profiling of MYBPC3-Associated Hypertrophic Cardiomyopathy Across Species Reveals Conservation of Biological Process But Not Gene Expression. J Am Heart Assoc. 2025 Jan 07; 14(1):e035780.
-
Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy. Eur Heart J. 2024 Dec 16; 45(47):5071-5083.
-
Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial. Eur Heart J. 2024 Nov 08; 45(42):4464-4478.
-
Standard-of-Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM. J Am Coll Cardiol. 2024 Nov 05; 84(19):1839-1849.
-
Aficamten and Cardiopulmonary Exercise Test Performance: A Substudy of the SEQUOIA-HCM Randomized Clinical Trial. JAMA Cardiol. 2024 Nov 01; 9(11):990-1000.
-
Myocardial Scarring and Sudden Cardiac Death in Young Patients With Hypertrophic Cardiomyopathy: A Multicenter Cohort Study. JAMA Cardiol. 2024 Nov 01; 9(11):1001-1008.
-
QRS prolongation is associated with associated with adverse cardiac remodeling in hypertrophic cardiomyopathy. J Electrocardiol. 2024 Nov-Dec; 87:153818.